AXON ENTERPRISE, INC.
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Nov 2, 2026 (7 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 26, 2026 | wwe dviw | maintain | — | — | — |
| Oct 20, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Sep 3, 2026 | Argus Research | maintain | Buy → Buy | — | 53% |
| Aug 6, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Aug 6, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Aug 6, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Aug 6, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jul 13, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Jul 6, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jun 25, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| May 8, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 7, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| May 7, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| May 7, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| May 7, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Apr 16, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Apr 13, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| Apr 8, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Apr 8, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Feb 25, 2026 | UBS | maintain | Neutral → Neutral | $570 | 54% |
| Feb 25, 2026 | Barclays | maintain | Overweight → Overweight | $682 | 53% |
| Feb 25, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $675 | 54% |
| Feb 25, 2026 | RBC Capital | maintain | Outperform → Outperform | $735 | 55% |
| Feb 25, 2026 | Piper Sandler | maintain | Overweight → Overweight | $690 | 54% |
| Feb 20, 2026 | Needham | maintain | Buy → Buy | $600 | 50% |
| Dec 17, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $713 | 54% |
| Nov 17, 2025 | RBC Capital | initiate | — → Outperform | $860 | 55% |
| Nov 6, 2025 | Barclays | maintain | Overweight → Overweight | $702 | 53% |
| Nov 5, 2025 | UBS | maintain | Neutral → Neutral | $610 | 54% |
| Nov 5, 2025 | Goldman Sachs | maintain | Buy → Buy | $800 | 54% |
| Nov 5, 2025 | Piper Sandler | maintain | Overweight → Overweight | $753 | 54% |
| Sep 29, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $825 | 53% |
| Sep 24, 2025 | Piper Sandler | initiate | — → Overweight | $893 | 54% |
| Sep 24, 2025 | Needham | reiterate | Buy → Buy | $870 | 50% |
| Aug 6, 2025 | B of A Securities | maintain | Buy → Buy | $1,000 | 53% |
| Aug 5, 2025 | Craig-Hallum | upgrade | Hold → Buy | $900 | 54% |
| Aug 5, 2025 | Northland Capital Markets | maintain | Outperform → Outperform | $800 | 50% |
| Aug 5, 2025 | Raymond James | maintain | Outperform → Outperform | $855 | 54% |
| Aug 5, 2025 | UBS | maintain | Neutral → Neutral | $840 | 54% |
| Aug 5, 2025 | Needham | maintain | Buy → Buy | $870 | 50% |
| Jul 22, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $825 | 53% |
| Jul 17, 2025 | JP Morgan | maintain | Overweight → Overweight | $850 | 54% |
| Jul 16, 2025 | UBS | initiate | — → Neutral | $820 | 54% |
| Jul 8, 2025 | Wolfe Research | initiate | — → Outperform | $0 | 53% |
| Jun 4, 2025 | B of A Securities | maintain | Buy → Buy | $895 | 53% |
| May 14, 2025 | Goldman Sachs | maintain | Buy → Buy | $830 | 54% |
| May 9, 2025 | Barclays | maintain | Overweight → Overweight | $735 | 53% |
| May 8, 2025 | Northland Capital Markets | maintain | Outperform → Outperform | $640 | 50% |
| May 8, 2025 | Needham | maintain | Buy → Buy | $750 | 50% |
| Apr 23, 2025 | Needham | reiterate | Buy → Buy | $600 | 50% |
No cross-platform signals in the last 90 days